LINC00221 and gastric cancer: He et al. demonstrated that LINC00221 is dysregulated in gastric cancer and competes with six miRNAs (hsa‐miR‐96, hsa‐miR‐143, hsa‐miR‐204, hsa‐miR‐372, hsa‐miR‐373 and hsa‐miR‐519d) to mediate target mRNA expression in gastric cancer [32].